Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04129021 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

High Resolution, High-speed Multimodal Ophthalmic Imaging

Study acronym: IMA-MODE
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Minor Re-verified, no change to tracked fieldsv3
  2. Notable Primary and study completion dates: Jun 30, 2023 to Jul 2027
    • Start date: Jul 15, 2019 to Jul 3, 2019
    • Study title expanded, about 3 words
    v2
  3. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Knowledge of the pathogenesis of ocular conditions, a leading cause of blindness, has benefited greatly from recent advances in ophthalmic imaging. However, current clinical imaging systems are limited in resolution, speed, or access to certain structures of the eye. The use of a high-resolution imaging system improves the resolution of ophthalmoscopes by several orders of magnitude, allowing the visualization of many microstructures of the eye: photoreceptors, vessels, nerve bundles in the retina, cells and nerves in the cornea. The use of a high-speed acquisition imaging system makes it possible to detect functional measurements such as the speed of blood flow. The combination of data from multiple imaging systems to obtain multimodal information is of great importance for improving the understanding of structural changes in the eye during a disease. The purpose of this project is to observe structures that are not detectable with routinely used systems.
Trial Details
NCT Number NCT04129021
Lead Sponsor Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts
Conditions
(from sponsor)
Retinitis Pigmentosa, Maculopathy, Age Related, Macular Dystrophy, Macular Edema, Retinal Detachment, Retinal Degeneration, Glaucoma, Vascular Inflammation +7 more
Related terms Corneal Dystrophies, Hereditary, Diabetes Mellitus, Dry Eye Syndromes, Glaucoma, Hypertension, Keratoconus, Macular Degeneration, Macular Edema, Retinal Degeneration, Retinal Detachment, Retinitis Pigmentosa, Stroke, Wounds and Injuries
Enrollment 1,200 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov